当前位置:首页 - 行情中心 - 常山药业(300255) - 财务分析 - 现金流量表

常山药业

(300255)

  

流通市值:221.06亿  总市值:221.40亿
流通股本:9.18亿   总股本:9.19亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金448,700,538.11226,574,610.71928,888,642.49768,522,243.45
  收到的税费返还5,006.121,440.878,198,288.88,170,495.71
  收到其他与经营活动有关的现金9,167,118.7410,263,936.2329,657,784.5232,326,771.17
  经营活动现金流入小计457,872,662.97236,839,987.81966,744,715.81809,019,510.33
  购买商品、接受劳务支付的现金294,622,173.39141,459,135.22614,771,064.29430,909,663.99
  支付给职工以及为职工支付的现金72,557,956.3641,720,214.55154,736,779.25122,148,023.58
  支付的各项税费11,411,870.774,047,709.237,176,717.3334,179,936.73
  支付其他与经营活动有关的现金58,686,767.1529,404,777.22104,377,276.6379,431,136.18
  经营活动现金流出小计437,278,767.67216,631,836.19911,061,837.5666,668,760.48
  经营活动产生的现金流量净额20,593,895.320,208,151.6255,682,878.31142,350,749.85
二、投资活动产生的现金流量:
  收到的其他与投资活动有关的现金168,061,000100,020,000157,263,980106,503,980
  投资活动现金流入小计168,061,000100,020,000157,263,980106,503,980
  购建固定资产、无形资产和其他长期资产支付的现金67,332,304.0529,427,247.04123,359,028.0472,037,176.77
  支付其他与投资活动有关的现金168,267,000100,017,000157,215,000106,568,000
  投资活动现金流出小计235,599,304.05129,444,247.04280,574,028.04178,605,176.77
  投资活动产生的现金流量净额-67,538,304.05-29,424,247.04-123,310,048.04-72,101,196.77
三、筹资活动产生的现金流量:
  取得借款收到的现金1,607,820,551.29800,549,551.292,200,738,918.631,984,038,918.63
  收到其他与筹资活动有关的现金66,670,00023,665,200411,046,00084,000,000
  筹资活动现金流入小计1,674,490,551.29824,214,751.292,611,784,918.632,068,038,918.63
  偿还债务支付的现金1,437,756,354.8675,515,428.262,239,344,873.111,954,652,648.58
  分配股利、利润或偿付利息支付的现金68,686,984.8828,474,359.64118,692,653.4789,652,045.43
  支付其他与筹资活动有关的现金74,013,67654,860,432312,291,15985,593,000
  筹资活动现金流出小计1,580,457,015.68758,850,219.92,670,328,685.582,129,897,694.01
  筹资活动产生的现金流量净额94,033,535.6165,364,531.39-58,543,766.95-61,858,775.38
四、汇率变动对现金及现金等价物的影响-995,274.74-729,624.22,282,864.872,765,798.57
五、现金及现金等价物净增加额46,093,852.1255,418,811.77-123,888,071.8111,156,576.27
  加:期初现金及现金等价物余额111,998,708.81111,998,708.81235,886,780.62235,886,780.62
  期末现金及现金等价物余额158,092,560.93167,417,520.58111,998,708.81247,043,356.89
补充资料:
  净利润-21,756,068.81--367,461,129.51-
  资产减值准备-560,212.28-166,861,830.69-
  固定资产和投资性房地产折旧28,378,511.77-58,346,528.92-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,378,511.77-58,346,528.92-
  无形资产摊销5,226,057.28-9,441,670.58-
  长期待摊费用摊销1,185,238.87-1,685,557.47-
  处置固定资产、无形资产和其他长期资产的损失6,296.23-7,377.37-
  固定资产报废损失1,230-221,024.8-
  财务费用46,333,350.4-94,573,966.98-
  投资损失---1,671,766.1-
  递延所得税2,579,938.45-2,425,252.92-
  其中:递延所得税资产减少2,601,139.13-2,467,654.26-
    递延所得税负债增加-21,200.68--42,401.34-
  存货的减少88,868,125.6-44,361,206.22-
  经营性应收项目的减少-136,493,926.51-12,286,062.9-
  经营性应付项目的增加5,713,002.06-32,315,828.61-
  现金的期末余额158,092,560.93-111,998,708.81-
  减:现金的期初余额111,998,708.81-235,886,780.62-
  现金及现金等价物的净增加额46,093,852.12--123,888,071.81-
公告日期2026-08-262026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑